Seattle, WA – February 3, 2026 – RevealDx, a leader in AI tools for the characterization of lung nodules,  announced FDA clearance of RevealAI-Lung. The company had previously announced MDR Certification in November of 2025. The RevealDx technology characterizes incidental lung nodules by producing a Malignancy Similarity Index (mSI™),  a […]